Xenon Pharmaceuticals Inc. (XENE)

NASDAQ: XENE · IEX Real-Time Price · USD

40.01

+0.13 (0.33%)

At close: Apr 22, 2024, 4:00 PM

38.01

-2.00 (-5.00%)

After-hours: Apr 22, 2024, 7:02 PM EDT

Xenon Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2011
Net Income	-182.39	-124.94	-77.09	-28.01	-40.03	-31.62	-30.7	-23	-15.75	13.02	Upgrade
Depreciation & Amortization	3.54	1.62	0.91	0.64	0.43	0.59	0.65	0.86	1.04	0.74	Upgrade
Share-Based Compensation	32.37	20.38	10.02	5.68	2.92	2.63	2.24	2.16	3.73	0.76	Upgrade
Other Operating Activities	1.15	4.94	-1.54	-25.61	33.53	-3.44	-0.91	0.41	-7.12	-14.25	Upgrade
Operating Cash Flow	-145.33	-98.43	-69.5	-48.12	-4.71	-34.72	-28.73	-19.57	-18.1	0.27	Upgrade
Capital Expenditures	-5.62	-2.89	-2.05	-2.64	-1.24	-0.51	-0.32	-0.28	-0.55	-1.53	Upgrade
Change in Investments	-111.55	-293.11	-244.72	-14.19	-64.97	-28.48	24.61	-47.56	10.75	-1.72	Upgrade
Investing Cash Flow	-117.17	-296	-246.77	-16.82	-66.21	-28.99	24.29	-47.84	10.19	-3.24	Upgrade
Share Issuance / Repurchase	353.52	278.47	447.54	102.54	27.52	103.14	0.18	23.96	0.28	42.66	Upgrade
Debt Issued / Paid	0	0	0	-16.74	0	8.45	6.89	0	0	0	Upgrade
Other Financing Activities	-	-	-	-	-	-	-	-	-	-1.53	Upgrade
Financing Cash Flow	353.52	278.47	447.54	85.8	27.52	111.59	7.07	23.96	0.28	41.12	Upgrade
Exchange Rate Effect	0.38	-2.48	-0.59	-0.59	0.41	-0.61	0.75	1.89	-5.74	-4.07	Upgrade
Net Cash Flow	91.4	-118.45	130.68	20.25	-43	47.27	3.39	-41.56	-13.38	34.08	Upgrade
Free Cash Flow	-150.94	-101.32	-71.55	-50.76	-5.95	-35.23	-29.04	-19.85	-18.65	-1.26	Upgrade
Free Cash Flow Margin	-	-1074.03%	-388.09%	-157.81%	-87.19%	-	-9337.94%	-1100.72%	-119.75%	-4.45%	Upgrade
Free Cash Flow Per Share	-2.26	-1.67	-1.64	-1.47	-0.23	-1.81	-1.61	-1.28	-1.31	-0.40	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).